Evidence map›Paper›PMID 32874607›Full record

ArticleRoyal Society open science2020

Photothermal-assisted antibacterial application of graphene oxide-Ag nanocomposites against clinically isolated multi-drug resistant

Yuqing Chen, Wei Wu, Zeqiao Xu, Cheng Jiang, Shuang Han, Jun Ruan, Yong Wang

Open access · goldAbstract read
In one paragraph

Article in Royal Society open science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Trends in Photothermal Nanostructures for Antimicrobial Applications.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Review
  8. Nanotechnology: A Potential Weapon to Fight against COVID-19.Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems · 2022
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yuqing ChenChildren's ENT Department, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, 214122 Wuxi, People's Republic of China.
Wei WuCardiothoracic Surgery Department, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, 214002 Wuxi, People's Republic of China.
Zeqiao XuUrology Surgery Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, 214122 Wuxi, People's Republic of China.
Cheng JiangDepartment of Laboratory Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, 214122 Wuxi, People's Republic of China.
Shuang HanSchool of Biotechnology, Jiangnan University, 214122 Wuxi, People's Republic of China.
Jun RuanUrology Surgery Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, 214122 Wuxi, People's Republic of China.
Yong WangUrology Surgery Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, 214122 Wuxi, People's Republic of China.ORCID 0000-0002-4244-852X
Wuxi People's Hospital · CNJiangnan University · CNNanjing Maternity and Child Health Care Hospital · CNWuxi No.2 People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the field of public health, treatment of multidrug-resistant (MDR) bacterial infection is a great challenge. Herein, we provide a solution to this problem with the use of graphene oxide-silver (GO-Ag) nanocomposites as antibacterial agent. Following established protocols, silver nanoparticles were grown on graphene oxide sheets. Then, a series of

Indexed as

graphene oxide-silverin vitroMDR E. coliphotothermal treatment

Identifiers

PMID32874607
PMCPMC7428222
OpenAlexW3045045368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.